Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 5,093 | 4,664 | 4,540 | 5,126 | 8,764 |
| Cost of Goods | 2,182 | 1,818 | 1,685 | 2,945 | 3,023 |
| Gross Profit | 2,911 | 2,846 | 2,855 | 2,181 | 5,741 |
| Operating Expenses | 8,313 | 8,988 | 9,103 | 10,477 | 9,594 |
| Operating Income | -5,220 | -5,324 | -5,563 | -7,351 | -3,830 |
| Interest Expense | 771 | 751 | 684 | 604 | 518 |
| Other Income | 9 | -528 | -8 | 129 | 93 |
| Pre-tax Income | -5,982 | -6,603 | -6,255 | -7,826 | -4,255 |
| Net Income Continuous | -5,982 | -6,603 | -6,255 | -7,826 | -4,255 |
| Net Income | $-5,982 | $-6,603 | $-6,255 | $-7,826 | $-4,255 |
| EPS Basic Total Ops | -1.12 | -1.28 | -1.28 | -1.68 | -0.88 |
| EPS Basic Continuous Ops | -1.15 | -1.30 | -1.26 | -1.60 | -0.88 |
| EPS Diluted Total Ops | -1.12 | -1.28 | -1.28 | -1.68 | -0.88 |
| EPS Diluted Continuous Ops | -1.15 | -1.30 | -1.26 | -1.60 | -0.88 |
| EBITDA(a) | $-5,133 | $-5,217 | $-5,455 | $-7,269 | $-3,646 |